Clinical Utility of Pro-inflammatory Oligomeric Glycoprotein Tenascin-C in the Diagnosis of Seropositive and Seronegative Rheumatoid Arthritis
- 13 September 2022
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 39 (1) , 110-117
Abstract
Owing to limited usefulness of Rheumatoid Factor and anti-CCP in rheumatoid arthritis, there is a need to identify a more sensitive and specific biomarker to detect rheumatoid arthritis (RA), particularly seronegative RA cases. Tenascin-C is an extracellular matrix glycoprotein, which has been implicated in the pathophysiology of RA. The objective of our study was to evaluate the diagnostic utility of serum Tenascin-C in seropositive and seronegative rheumatoid arthritis patients. We conducted a cross-sectional case control study. Sixty patients who fulfilled the ACR 2010 criteria for rheumatoid arthritis were included in the study. Thirty patients were found to be positive for RF and/or anti-CCP and 30 were negative for both RF and anti-CCP. Thirty age and gender-matched healthy subjects were taken as controls. Serum Tenascin-C was measured by quantitative sandwich enzyme immunoassay technique. The mean serum concentration of Tenascin-C in controls, seronegative and seropositive cases was 0.66 ng/ml, 20.54 ng/ml and 23.42 ng/ml, respectively. Tenascin-C levels were significantly higher in RA cases compared to controls (p < 0.0001). There was no significant difference in Tenascin-C between seropositive and seronegative cases (p = 0.603). ROC curve analysis showed a sensitivity of 96.6% and specificity of 100% with AUC of 0.98 at 2.21 ng/ml as cut-off value for diagnosing RA. Tenascin-C is elevated in both seronegative and seropositive RA, which indicates that it can be used as a sensitive marker for RA. The addition of Tenascin-C to the existing RF and anti-CCP may help in identifying a large number of patients with RA, particularly seronegative rheumatoid arthritis cases.Keywords
This publication has 23 references indexed in Scilit:
- Raised circulating tenascin-C in rheumatoid arthritisArthritis Research & Therapy, 2012
- Advances in tenascin-C biologyCellular and Molecular Life Sciences, 2011
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Transcriptional Regulation of the Endogenous Danger Signal Tenascin-C: A Novel Autocrine Loop in InflammationThe Journal of Immunology, 2010
- The role of tenascin-C in tissue injury and tumorigenesisJournal of Cell Communication and Signaling, 2009
- α9 Integrin and Its Ligands Constitute Critical Joint Microenvironments for Development of Autoimmune ArthritisThe Journal of Immunology, 2009
- Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitopeAnnals of the Rheumatic Diseases, 2007
- Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2004
- Overview of work disability in rheumatoid arthritis patients as observed in cross‐sectional and longitudinal surveysArthritis Care & Research, 2004
- Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 1994